What Happened?
San Diego, -based Neurocrine Promoted Ingrid Delaet as Chief Regulatory Officer
About the Company
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company`s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson`s disease, endometriosis* and uterine fibroids* , as well as clinical programs in multiple therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science.
About the Person
Ingrid Delaet is Chief Regulatory Officer at Neurocrine. Previously, Ingrid held various senior legal leadership roles in the industry.
Info Source
News
Short Profile